Sovereign Pharmaceuticals, LLC

Form 483 issued January 12, 2018 · Fort Worth, Texas

Inspection
Jan 8 – Jan 12, 2018
Observations
2
Pages
3
FEI number
3003229412

In short: On January 12, 2018, FDA issued a Form 483 with 2 observations to Sovereign Pharmaceuticals, LLC in Fort Worth, Texas (FEI 3003229412) after an inspection that ran Jan 8 – Jan 12, 2018. The investigator was Patty P. Kaewussdangkul. Most observations concern laboratory controls and materials.

At a glance

Laboratory controls and materials account for 2 of 2 observations.

Laboratory controls1
Materials1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The written stability testing…

  2. 02

    Written procedures are not followed for…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Sovereign Pharmaceuticals, LLC?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and materials. The opening words of each observation are shown on this page.

Who inspected Sovereign Pharmaceuticals, LLC?

Patty P. Kaewussdangkul is named on this Form 483, for the inspection of Jan 8 – Jan 12, 2018. Each investigator has a profile showing what they cite most.

When was Sovereign Pharmaceuticals, LLC inspected by FDA?

The inspection ran Jan 8 – Jan 12, 2018, and the Form 483 is dated January 12, 2018.

How do I get the full Form 483 for Sovereign Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free